CD300A Human

CD300A Human Recombinant
Cat. No.
BT28469
Source
Escherichia Coli.
Synonyms
CD300a Molecule, CD300a Antigen, IRp60, CD300 Antigen-Like Family Member A, NK Inhibitory Receptor, Immunoglobulin Superfamily Member 12, CMRF35-Like Molecule 8, CMRF35-H, Inhibitory Receptor Protein 60, CMRF-35-H9, CMRF-35H, CLM-8, IRC1, IRC2, CMRF35H Leukocyte Immunoglobulin-Like Receptor, Leukocyte Membrane Antigen, IgSF12.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 90% as determined by SDS-PAGE.
Usage

THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Shipped with Ice Packs
In Stock

Description

CD300A Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 134 amino acids (18-128) and having a molecular mass of 14.7kDa.
CD300A is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
CD300A, a member of the CD300 family, possesses a single Ig-like V-type (immunoglobulin-like) domain. This protein is expressed on various immune cells, including natural killer (NK) cells, T-cell subsets, B-cells, dendritic cells, mast cells, granulocytes, and monocytes. As an inhibitory receptor, CD300A plays a role in downregulating the cytolytic activity of NK cells and mast cell degranulation.
Description
Recombinant human CD300A, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 134 amino acids (residues 18-128). It has a molecular weight of 14.7 kDa. The protein is fused to a 23 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
A sterile, colorless solution that has been filtered.
Formulation
The CD300A solution is formulated in 20mM Tris-HCl buffer with a pH of 8.0, 0.15M NaCl, 1mM DTT, and 10% glycerol.
Stability
The product should be stored at 4°C for 2-4 weeks if the entire vial will be used. For longer storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of the product is greater than 90% as determined by SDS-PAGE analysis.
Synonyms
CD300a Molecule, CD300a Antigen, IRp60, CD300 Antigen-Like Family Member A, NK Inhibitory Receptor, Immunoglobulin Superfamily Member 12, CMRF35-Like Molecule 8, CMRF35-H, Inhibitory Receptor Protein 60, CMRF-35-H9, CMRF-35H, CLM-8, IRC1, IRC2, CMRF35H Leukocyte Immunoglobulin-Like Receptor, Leukocyte Membrane Antigen, IgSF12.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSLSKCRTV AGPVGGSLSV QCPYEKEHRT LNKYWCRPPQ IFLCDKIVET KGSAGKRNGR VSIRDSPANL SFTVTLENLT EEDAGTYWCG VDTPWLRDFH DPVVEVEVSV FPAS

Product Science Overview

Structure and Expression

CD300A is a type I transmembrane receptor characterized by an extracellular IgV-like domain and a cytoplasmic tail containing three classic immunoreceptor tyrosine-based inhibitory motifs (ITIMs) . These ITIMs are essential for the inhibitory signaling functions of CD300A. The receptor is broadly expressed on various immune cells, including myeloid and lymphoid cells .

Ligand Recognition and Signaling

CD300A recognizes and binds to specific lipids, such as phosphatidylserine and phosphatidylethanolamine, which are exposed on the outer leaflet of the plasma membrane of dead and activated cells . Upon ligand binding, the ITIMs in the cytoplasmic tail of CD300A become phosphorylated, initiating a cascade of inhibitory signals that modulate immune cell functions .

Functional Role

The primary function of CD300A is to inhibit immune cell activation and maintain immune homeostasis. It achieves this by dampening the activation signals from other receptors. For instance, CD300A can inhibit natural killer (NK) cell-mediated cytotoxicity, FcγRIIa-mediated reactive oxygen species production in neutrophils, and FcϵRI-mediated activation of mast cells . This inhibitory function is crucial in preventing excessive immune responses and maintaining tolerance to self-antigens .

Clinical Relevance

CD300A has significant clinical relevance due to its role in various pathological conditions. It has been implicated in the pathogenesis of infectious diseases, cancer, allergies, and chronic inflammatory diseases . For example, in a murine model of asthma, targeting CD300A with a bispecific antibody linking it to CCR3 reversed airway inflammation and remodeling . Additionally, CD300A has been studied as a potential therapeutic target for modulating immune responses in various disease states .

Recombinant CD300A

Recombinant CD300A is a laboratory-produced version of the natural protein, designed to mimic its structure and function. It is used in research to study the receptor’s role in immune regulation and to develop potential therapeutic interventions. Recombinant proteins are typically produced using expression systems such as bacteria, yeast, or mammalian cells, and are purified to ensure their functionality and stability.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.